Latest Breaking News On - Tilray medical expands portfolio - Page 1 : comparemela.com

Tilray Q1 Cannabis Revenue Increases 10% Sequentially to $58 6 Million

Tilray Brands’ First Quarter Fiscal Year 2023 Performance Affirms Global Cannabis Leadership. Reported Net Revenue at $153.2 Million; On a Constant Currency Basis, Net Revenue. #TilrayBrands #TLRY

United statesNew zealandUnited kingdomWestern australiaIrwind simonCompany nasdaqSweetwater brewing companyCompany reconfirms guidance toDenver broncos releaseCompany consolidated statements of operationsRepublic national distributing companyRose life sciencesCannapoint program to support patients across canadaInsight health sales dataBudtender association collector cupTilray brands inc

Tilray Brands First Quarter Fiscal Year 2023 Performance Affirms Global Cannabis Leadership

Tilray Brands First Quarter Fiscal Year 2023 Performance Affirms Global Cannabis Leadership
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesNew zealandUnited kingdomWestern australiaRaphael grossBerrin noorataIrwind simonCompany nasdaqSweetwater brewing companyCompany reconfirms guidance toDenver broncos releaseCompany consolidated statements of operationsRose life sciencesRepublic national distributing companyCannapoint program to support patients across canadaInsight health sales data

Tilray, Inc (TLRY) Reports Q1 Revenue of $153 2M, Net Loss of $66M

Tilray, Inc (TLRY) Reports Q1 Revenue of $153 2M, Net Loss of $66M
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesNew zealandUnited kingdomWestern australiaRaphael grossBerrin noorataIrwind simonSweetwater brewing companyDenver broncos releaseCompany consolidated statements of operationsRepublic national distributing companyRose life sciencesCannapoint program to support patients across canadaInsight health sales dataBudtender association collector cupSweetwater brewing company unveils new fall craft

Tilray Medical Expands Portfolio of Medical Cannabis Products in the UK

Tilray Medical Expands Portfolio of Medical Cannabis Products in the UK GlobeNewswire June 29, 2022 LEAMINGTON, Ontario, June 29, 2022 (GLOBE NEWSWIRE) Tilray Brands, Inc. ("Tilray" or the "Company") (Nasdaq: TLRY; TSX: TLRY), a leading global cannabis-lifestyle and consumer packaged goods company inspiring and empowering the worldwide community to live their.

United statesNew zealandUnited kingdomRaphael grossBerrin noorataDenise faltischekCompany nasdaqHead of international businessSecurities exchangeTilray brands incTilray medical expands portfolioMedical cannabis productsTilray medicalChief strategy officerInternational businessBroken coast